India Heads High on Neem Patent Saga - Patent Analytics report

Asset - India Heads High on Neem Patent Saga - Patent Analytics report

Good afternoon. Today, I learned all about Asset - India Heads High on Neem Patent Saga - Patent Analytics report. Which could be very helpful in my experience therefore you. India Heads High on Neem Patent Saga - Patent Analytics report

Neem (Azadirachta indica) is a tree in the mahogany family Meliaceae. It is one of two species in the genus Azadirachta, and is native to India, Myanmar, Bangladesh, Sri Lanka and Pakistan growing in tropical and semi-tropical regions. In East Africa it is also known as Mwarobaini (Swahili), which means the tree of the 40, as it is said to treat 40 distinct diseases.

What I said. It is not the conclusion that the actual about Asset. You check this out article for info on anyone want to know is Asset.

Asset

Traditional uses of Neem
1. Neem acts as anti bacterial, anti parasitic, anti fungal, anti protozoal and anti viral thus helps in security from all the microorganisms, which are all the time ready to invade in our body causing serious ailments.
2. Local application of neem powder or neem oil has miraculous results. As it is a celebrated anti microbial herb, it renders all the microorganisms inactive therefore helping in allowable medical of wound without causing any infections and septic conditions.
3. Taking bath of neem leaves water is a very base sight in Indian homes that helps our body to counter mild infections, which our body might get in day-to-day activity.
4. Its tropical application makes us relieved from acne, eczema and even ringworms.
5. In skin associated diseases, neem works as blessing of God on mankind. It has an action on almost every kind of skin disease thus production its indication in eradicating every kind of itch, rash, infection and allergy.
6. Neem water is extensively used in burn injuries, thus to safe them from any kind of infection and also promote healing.
7. Neem oil is extensively used in hair fall and early graying of hairs with very satisfying results. It also find its application in dandruff and in lice growth.
8. Its local application on arthritic conditions like rheumatoid arthritis, gout, Osteoarthritis, lower back pain, and musculo skeletal pains is very recommended with good results.

Dolcera Analysis

1. Top Assignees in India and Us on Neem patents: We analyzed a total of 98 relevant patents published in India on Neem and 78 relevant patents published in Us on Neem from 2006 to 27th June 2009.
A. One can inspect from the above graph that Csir is the important assignee in both Us and in India. It means that essential study on Neem is being carried out by Csir.
B. In India, Csir is being followed by Kalyani Chemicals, Indian council for agriculture corollary (Icar), Godrej agrovet, Defense study and development Organisation (Drdo).
C. In Us, Csir (India) remains the top filler followed by Uop Llc and Syngenta Corp security Inc.

2. Applications of Neem on which Indian and Us assignees filled patents: Next, we compared the Applications of neem for which the patents are sought in both Us and India.
A. The major application of neem in most of the publication is on Pest control.
B. Indian publication concentrates on the healthful aspects of neem whereas Us publications concentrates mostly on the insect repellant property of neem.
C. Indian assignees have patented use of Neem for its healthful benefits such as for wound healing, wound coating, diabetes, Hiv/ Aids and skin care.
D. Us assignees looked more interested in the areas such as Biodesel production, fertilizers, dental formulations, food packaging, cosmetics and Pharmaceutical compositions.

3. Sector wise distribution for Indian patents on Neem: We tried to find out the major gift of various sectors in publishing patents on neem and found that private Application of patents has major part in the distribution of publication on neem in India followed by the secret sectors and then the government.

Neem patent in India are mostly held by individuals, 41.84% followed by secret sectors, 31.63%. Government institutes lagged behind all and maintain only 26.53% patents on India's former asset, Neem.

4. Dolcera end Indians have all the time cherished their former knowledge, patrimony and culture. Neem is one such patrimony and an integral part of our socio-economical culture. From times immemorial Neem has found use as an intergradient in Indian culinary, as a treatment for cure of some allergies/diseases and in various religious ceremonies across the country. Time and again there has been a hue and cry to stop other countries from patenting this age old Indian knowledge of Neem. This study, is aimed to write back the key request Are Indians retention an upper hand, legally too, on Neem usage? Comparing the trend of patent filing in India and Us in the middle of 2006 to June 2009, we can safely desist that India as a whole has risen up to the expectations and has filled 98 patents on technology surrounding Neem. Csir (India) played a key role here in India as well as in Us to remain as top assignee in the terms of estimate of patent fillings on application of Neem. However, the faultless photograph can be alarming. Form this, despite Csir remaining as the top assignee, patents on Neem in India are mostly held by individuals (41.84%), followed by secret sector, 31.63%. Government institutes (which included Csir, Drdo, Icar, Iihr etc) lagged behind all and maintain only 26.53% of patents on India's former asset. While Indians have used Neem for its healthful benefits such as for wound healing, diabetes, Hiv/ Aids and skin care; Us assignees looked more interested in the areas such as Biodesel production, fertilizers, dental formulations, food packaging, pharmaceutical compositions etc. This study was aimed to gain in depth insight of patenting trends on Neem in India and Us. Waking up to the cause, India has done well to broadly cover the Neem application areas but the efforts should increase exponentially to maintain the legal proprietary on Neem, the gift of nature to India.

Disclaimer: Above study was conducted using the Indian patent quest database in case,granted by the Indian patent office and Micropat. The study was a broad level quest and we might have missed out on few patents. The diagnosis is prone to human errors and can have marginal errors. Dolcera holds all proprietary on this publication and it should not be used without the consent of authors and the company.

I hope you have new knowledge about Asset. Where you can offer easy use in your daily life. And just remember, your reaction is passed about Asset.